AGENUS INC - 04 Oct 2023 Form 4 Insider Report for MiNK Therapeutics, Inc. (INKT)

Role
10%+ Owner
Signature
/s/Christine Klaskin, Vice President, Finance
Issuer symbol
INKT
Transactions as of
04 Oct 2023
Net transactions value
+$16,380
Form type
4
Filing time
06 Oct 2023, 16:26:25 UTC
Previous filing
31 Aug 2023
Next filing
16 Oct 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INKT Common Stock Purchase $16,380 +15,001 +0.07% $1.09 21,749,888 04 Oct 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Open market purchases reported on this line occurred at a weighted average price of $1.0919 (range of $1.02 to $1.10).
F2 Agenus Inc. undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares purchased at each separate price.